Your browser doesn't support javascript.
loading
A novel irinotecan derivative ZBH-1207 with different anti-tumor mechanism from CPT-11 against colon cancer cells.
Zhao, Dawei; Wu, Di; Zhang, Gengyue; Li, Yongqi; Shi, Weiguo; Zhong, Bohua; Yu, Hong.
Affiliation
  • Zhao D; Department of Breast Tumor, Jilin Cancer Hospital, No.1018 Hu-Guang Road, Changchun, 130012, China.
  • Wu D; Tumor Center of Jilin University No.1 Hospital, No.71 Xin-Min Street, Changchun, 130021, China.
  • Zhang G; Cell Biology Laboratory, Jilin Province Tumor Institute, Jilin Cancer Hospital, No.1018 Hu-Guang Road, Changchun, 130012, China.
  • Li Y; Tumor Center of Jilin University No.1 Hospital, No.71 Xin-Min Street, Changchun, 130021, China.
  • Shi W; Institute of Pharmacology and Toxicology Academy of Military Medical Sciences, No.27 Tai-Ping Road, Beijing, 100850, China.
  • Zhong B; Institute of Pharmacology and Toxicology Academy of Military Medical Sciences, No.27 Tai-Ping Road, Beijing, 100850, China.
  • Yu H; Cell Biology Laboratory, Jilin Province Tumor Institute, Jilin Cancer Hospital, No.1018 Hu-Guang Road, Changchun, 130012, China. yhzhlyy@126.com.
Mol Biol Rep ; 49(9): 8359-8368, 2022 Sep.
Article in En | MEDLINE | ID: mdl-35764749

Full text: 1 Database: MEDLINE Main subject: Colonic Neoplasms / Antineoplastic Agents, Phytogenic Limits: Humans Language: En Journal: Mol Biol Rep Year: 2022 Type: Article Affiliation country: China

Full text: 1 Database: MEDLINE Main subject: Colonic Neoplasms / Antineoplastic Agents, Phytogenic Limits: Humans Language: En Journal: Mol Biol Rep Year: 2022 Type: Article Affiliation country: China